4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

ʻO ka wehewehe pōkole:

Inoa Kemika: 4-Aminopyridine

CAS: 504-24-5

ʻIke: ≥99.5% (HPLC)

ʻAno: Keʻokeʻo a i ʻole ka pauda kristal melemele liʻiliʻi

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Manufacturer Supply, High Purity, Commercial Production
Inoa Kemika: 4-Aminopyridine
CAS: 504-24-5

Na Waiwai Kemika:

Inoa Kimia 4-Aminopyridine
Nā huaʻōlelo like 4-AP;4-Pyridinamine;Fampridine;Dalfampridine;p-Aminopyridine;γ-Aminopyridine
Helu CAS 504-24-5
Helu CAT RF-PI539
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C5H6N2
Kaumaha Molecular 94.12
Ka hoʻoheheʻe Hiki i ka wai, ethanol
Brand ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Keʻokeʻo a i ʻole ka pauda Crystalline Melemele Lihi
Hana ʻIke / ʻIke ≥99.5% (HPLC)
Lae hehee 157.0~162.0 ℃
Wai (KF) ≤0.50%
Lehu Sulphated ≤0.20%
2-Aminopyridine ≤0.10%
3-Aminopyridine ≤0.10%
Huina paumaele ≤0.50%
Kūlana hoʻāʻo ʻOihana Kūlana
Hoʻohana Nā Kūwaena Lapaʻau;API

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

1

FAQ:

Noi:

ʻO 4-Aminopyridine (CAS: 504-24-5) kekahi o nā amine isomeric ʻekolu o pyridine, he mea maʻemaʻe, synthetic, a me ka biologically active compound, hoʻohana nui ʻia i ka synthesis organic, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API). ) hoʻohuihui.Hoʻohana ʻia ʻo 4-Aminopyridine (4-AP, Fampridine, Dalfampridine) ma ke ʻano he mea noiʻi noiʻi i ka ʻike ʻana i nā subtypes o ke kahawai potassium.Ua hoʻohana ʻia ʻo ia ma ke ʻano he lāʻau lapaʻau, no ka mālama ʻana i kekahi o nā hōʻailona o ka maʻi sclerosis, a ua hōʻike ʻia no ka hoʻomaikaʻi ʻana o ka hele ʻana i nā pākeke me nā ʻano like ʻole o ka maʻi.Ua ʻae ka US Food and Drug Administration (FDA) i ka hui ma Ianuali 22, 2010. Ua kūʻai ʻia ʻo Fampridine ma ʻAmelika Hui Pū ʻIa e Acorda Therapeutics a ʻo Fampyra i ka European Union, Canada, a me Australia.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou